Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Change in Cash (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Change in Cash readings, the most recent being -$4.7 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 60.55% to -$4.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$33.4 million, a 13.6% decrease, with the full-year FY2025 number at -$40.5 million, down 36.57% from a year prior.
  • Change in Cash hit -$4.7 million in Q1 2026 for Barinthus Biotherapeutics, down from -$3.8 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $7.8 million in Q3 2022 to a low of -$18.3 million in Q2 2023.
  • Median Change in Cash over the past 5 years was -$11.8 million (2025), compared with a mean of -$8.6 million.
  • Biggest five-year swings in Change in Cash: surged 179.78% in 2022 and later tumbled 296.43% in 2024.
  • Barinthus Biotherapeutics' Change in Cash stood at -$5.7 million in 2022, then tumbled by 218.57% to -$18.2 million in 2023, then soared by 134.57% to $6.3 million in 2024, then crashed by 160.69% to -$3.8 million in 2025, then dropped by 22.0% to -$4.7 million in 2026.
  • The last three reported values for Change in Cash were -$4.7 million (Q1 2026), -$3.8 million (Q4 2025), and -$12.1 million (Q3 2025) per Business Quant data.